These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12500036)

  • 21. Lung cancer and hormone replacement therapy.
    Barton M; Meyer MR; Bolton JL; Prossnitz ER
    Lancet; 2010 Jan; 375(9709):117-8; author reply 118-9. PubMed ID: 20109881
    [No Abstract]   [Full Text] [Related]  

  • 22. Women's health issues.
    Kaiser FE
    Med Clin North Am; 2003 Sep; 87(5):xi-xiii. PubMed ID: 14621323
    [No Abstract]   [Full Text] [Related]  

  • 23. Estrogens and women's health: a scary or a fairy tale?
    Genazzani AR; Gambacciani M; Simoncini T
    Gynecol Endocrinol; 2004 Apr; 18(4):175-8. PubMed ID: 15293887
    [No Abstract]   [Full Text] [Related]  

  • 24. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. Part 4: the Million Women Study.
    Shapiro S; Farmer RD; Stevenson JC; Burger HG; Mueck AO
    J Fam Plann Reprod Health Care; 2012 Apr; 38(2):102-9. PubMed ID: 22262621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference of progestins with endothelial actions of estrogens: a matter of glucocorticoid action or deprivation?
    Arnal JF; Gourdy P; Simoncini T
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):441-3. PubMed ID: 19179642
    [No Abstract]   [Full Text] [Related]  

  • 26. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 27. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract]   [Full Text] [Related]  

  • 29. The Women's Health Initiative. Implications for practice.
    Furniss K
    Adv Nurse Pract; 2002 Nov; 10(11):53-5. PubMed ID: 12478949
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
    Klein KP; Rapp SR
    Womens Health Issues; 2004; 14(3):71-4. PubMed ID: 15193634
    [No Abstract]   [Full Text] [Related]  

  • 32. [Coronary artery disease and menopausal hormone therapy].
    Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z; Holecki M
    Pol Arch Med Wewn; 2004 Oct; 112(4):1255-63. PubMed ID: 15773440
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 34. [Caring for women during perimenopause in the practice].
    Beckermann MJ
    Ther Umsch; 2005 Dec; 62(12):813-20. PubMed ID: 16405286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating its impact. The Women's Health Initiative.
    Theroux R
    AWHONN Lifelines; 2005; 9(2):140-5. PubMed ID: 15926271
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormone replacement therapy: practical aspects].
    Sonigo C; Dray G; Chabbert-Buffet N
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F3-12. PubMed ID: 23062744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turbulent times for hormone replacement therapy: is there a way out?
    Verhaeghe J
    Gynecol Obstet Invest; 2003; 56(1):43-50. PubMed ID: 12876424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
    Ylikorkala O
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
    [No Abstract]   [Full Text] [Related]  

  • 39. Negative Women's Health Initiative findings stir consternation, debate among researchers.
    Twombly R
    J Natl Cancer Inst; 2006 Apr; 98(8):508-10. PubMed ID: 16622115
    [No Abstract]   [Full Text] [Related]  

  • 40. Discussing breast cancer and hormone replacement therapy with women.
    Batur P; Thacker HL; Moore HC
    Cleve Clin J Med; 2002 Nov; 69(11):838, 840, 843-4 passim. PubMed ID: 12430969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.